Periodic safety reporting schedule

Active Substances	Trade Name	MAH	Year of registration in Saudi Arabia	International Birth Date (IBD)	PSUR Submission Frequency	Data Lock Point (DLP)	Submission Date
SAXAGLIPTIN	ONGLYZA	AstraZeneca	2011-01-01	2009-07-31	3 years	2017-07-30	2017-10-28
Ibuprofen (indicated in ductus arteriosus)	JAZOFEN	Jazeera Pharmaceutical Industries (JPI)	1999-01-01	2004-07-29	3 years	2017-07-29	2017-10-27
Ibuprofen (indicated in ductus arteriosus)	BALKAPROFEN	APM	1982-01-01	2004-07-29	3 years	2017-07-29	2017-10-27
Ibuprofen	NUFEN	Hikma Pharmaceuticals PLC	1987-01-01	2004-07-29	3 years	2017-07-29	2017-10-27
Ribavirin	ribavirin	APM	2004-01-01	1999-05-07	3 years	2017-07-24	2017-10-22
Natalizumab	Tysabri	Algorithm	2014-01-01	2006-06-27	annual	2017-08-07	2017-10-16
Idursulfase	Elaprase	Algorithm	2016-01-01	2007-01-08	annual	2017-07-23	2017-10-01
Epirubicin	EPIRUBICIN JAZEERA	Jazeera Pharmaceutical Industries (JPI)	2014-01-01	1982-06-28	3 years	2017-06-30	2017-09-28
METHOTREXATE	METHOTREXATE	SANOFI PASTEUR	1992-01-01	1962-01-01	3 years	2020-06-30	2017-09-28
Oxytocin	GYNOCIN	Jazeera Pharmaceutical Industries (JPI)	2016-01-01	1955-02-06	3 years	2017-06-30	2017-09-28

Share page